Literature DB >> 34230997

Search for Novel Plasma Membrane Proteins as Potential Biomarkers in Human Mesenchymal Stem Cells Derived from Dental Pulp, Adipose Tissue, Bone Marrow, and Hair Follicle.

Gurler Akpinar1, Kubra Karaosmanoglu Yoneten2, Murat Kasap3, Erdal Karaoz4.   

Abstract

One of the drawbacks preventing the use of mesenchymal stem cells (MSCs) in clinical practice is the heterogeneous nature of their cultures. MSC cultures are not homogeneously formed by the MSCs and may contain non-mesenchymal cell types. Therefore, prior to use in clinics or research, complete characterization of MSCs should be performed to demonstrate the existence or absence of proper stem cell markers, many of which are happened to be cell-surface proteins. Unfortunately, the success of MSC characterization studies is limited due to the low specificity of the currently available cell-surface markers. Therefore, in this study, we aimed to investigate the plasma membrane (PM) proteins of MSCs isolated from human dental pulp (DP), adipose tissue (AT), bone marrow (BM), and hair follicle (HF) with the hope of proposing novel putative specific MSC markers. Differential-velocity centrifugation was used to enrich PM proteins. The isolated proteins were then identified by nLC-MS/MS and subjected to bioinformatics analysis. Proteins that were unique to each MSC type (CD9, CD10, CD63 for DP-MSCs; CD26, CD81, CD201, CD364 for AT-MSCs; Cd49a, CD49d for HF-MSCs; CD49e, CD56, CD92, CD97, CD156b, CD156c, CD220, CD221, CD298, CD315 for BM-MSCs) and common to all four MSC types (CD13, CD29, CD44, CD51, CD59, CD73, CD90) were identified. Uncharacterized proteins that have transmembrane (TM) domains were also detected. Some of the proteins identified in this study were the putative cell-surface markers that might be used for characterization of MSCs.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CDs; Mesenchymal stem cell markers; Plasma membrane proteomics; nLC-MS/MS

Mesh:

Substances:

Year:  2021        PMID: 34230997     DOI: 10.1007/s00232-021-00190-1

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  41 in total

1.  Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.

Authors:  Héctor F Araya; Hugo Sepulveda; Carlos O Lizama; Oscar A Vega; Sofia Jerez; Pedro F Briceño; Roman Thaler; Scott M Riester; Marcelo Antonelli; Flavio Salazar-Onfray; Juan Pablo Rodríguez; Ricardo D Moreno; Martin Montecino; Martine Charbonneau; Claire M Dubois; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Biochem       Date:  2018-06-19       Impact factor: 4.429

2.  Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells.

Authors:  Natasha Baker; Guofeng Zhang; Yang You; Rocky S Tuan
Journal:  J Cell Biochem       Date:  2012-12       Impact factor: 4.429

3.  Profiling stem cell states in three-dimensional biomaterial niches using high content image informatics.

Authors:  Anandika Dhaliwal; Matthew Brenner; Paul Wolujewicz; Zheng Zhang; Yong Mao; Mona Batish; Joachim Kohn; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2016-08-31       Impact factor: 8.947

4.  Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells.

Authors:  Sandrine Cappellesso-Fleury; Bénédicte Puissant-Lubrano; Pol-André Apoil; Matthias Titeux; Peter Winterton; Louis Casteilla; Philippe Bourin; Antoine Blancher
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

Review 5.  Human mesenchymal stem cells: from basic biology to clinical applications.

Authors:  B M Abdallah; M Kassem
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

6.  Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype.

Authors:  Frederic Deschaseaux; Florelle Gindraux; Rafika Saadi; Laurent Obert; David Chalmers; Patrick Herve
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

7.  Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro.

Authors:  Ludovica Bruno; Reinhard Hoffmann; Fraser McBlane; John Brown; Rajeev Gupta; Chirag Joshi; Stella Pearson; Thomas Seidl; Clare Heyworth; Tariq Enver
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers.

Authors:  Anja M Billing; Hisham Ben Hamidane; Shaima S Dib; Richard J Cotton; Aditya M Bhagwat; Pankaj Kumar; Shahina Hayat; Noha A Yousri; Neha Goswami; Karsten Suhre; Arash Rafii; Johannes Graumann
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

9.  Comprehensive Screening of Cell Surface Markers Expressed by Adult-Derived Human Liver Stem/Progenitor Cells Harvested at Passage 5: Potential Implications for Engraftment.

Authors:  Pierre-Edouard Dollet; Joachim Ravau; Floriane André; Mustapha Najimi; Etienne Sokal; Catherine Lombard
Journal:  Stem Cells Int       Date:  2016-11-13       Impact factor: 5.443

10.  Mapping of equine mesenchymal stromal cell surface proteomes for identification of specific markers using proteomics and gene expression analysis: an in vitro cross-sectional study.

Authors:  Louise Bundgaard; Allan Stensballe; Kirstine Juul Elbæk; Lise Charlotte Berg
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

View more
  1 in total

Review 1.  Dental Pulp Stem Cell Heterogeneity: Finding Superior Quality "Needles" in a Dental Pulpal "Haystack" for Regenerative Medicine-Based Applications.

Authors:  Zi Y Kok; Nadia Y A Alaidaroos; Amr Alraies; John S Colombo; Lindsay C Davies; Rachel J Waddington; Alastair J Sloan; Ryan Moseley
Journal:  Stem Cells Int       Date:  2022-01-04       Impact factor: 5.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.